Acasti Pharma Inc. financial data

Symbol
ACST on Nasdaq
Industry
Pharmaceutical Preparations
Location
103 Carnegie Center, Suite 300, Princeton, NJ
State of incorporation
Quebec, Canada
Fiscal year end
March 31
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.34K % +37%
Debt-to-equity 17.8 % -4.2%
Return On Equity -18.1 % +64.5%
Return On Assets -15.4 % +64.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.4M shares -78.9%
Common Stock, Shares, Outstanding 9.4M shares +26.4%
Entity Public Float 17.6M USD
Common Stock, Value, Issued 258M USD +0.04%
Weighted Average Number of Shares Outstanding, Basic 10.9M shares +47%
Weighted Average Number of Shares Outstanding, Diluted 10.9M shares +47%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.3M USD -25.7%
Selling and Marketing Expense 252K USD -61.9%
General and Administrative Expense 6.81M USD -9.99%
Operating Income (Loss) -13.4M USD +74.2%
Nonoperating Income (Expense) -353K USD -198%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -13.7M USD +73.4%
Income Tax Expense (Benefit) -2.27M USD +76.4%
Net Income (Loss) Attributable to Parent -11.4M USD +72.7%
Earnings Per Share, Basic -1.05 USD/shares +81.4%
Earnings Per Share, Diluted -1.05 USD/shares +81.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.4M USD -10.4%
Accounts Receivable, after Allowance for Credit Loss, Current 398K USD -52.4%
Assets, Current 20.4M USD -13.5%
Property, Plant and Equipment, Net 24K USD -76.9%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 41.1M USD 0%
Goodwill 8.14M USD 0%
Assets 69.7M USD -4.54%
Employee-related Liabilities, Current 237K USD -16.8%
Accrued Liabilities, Current 814K USD -18.1%
Liabilities, Current 2.6M USD +32.2%
Deferred Income Tax Liabilities, Net 4.79M USD -32.1%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 10.4M USD +14.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.04M USD 0%
Retained Earnings (Accumulated Deficit) -214M USD -5.66%
Stockholders' Equity Attributable to Parent 59.4M USD -7.26%
Liabilities and Equity 69.7M USD -4.54%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.6M USD +42.4%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -15K USD
Common Stock, Shares, Issued 9.4M shares +26.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.61M USD +42.2%
Deferred Tax Assets, Valuation Allowance 47.3M USD +1.33%
Deferred Tax Assets, Gross 51.6M USD +11.1%
Operating Lease, Liability 0 USD -100%
Depreciation 1K USD -85.7%
Lessee, Operating Lease, Liability, to be Paid 24K USD
Property, Plant and Equipment, Gross 722K USD +1.26%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 105K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 24K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 108K USD
Deferred Tax Assets, Operating Loss Carryforwards 40.7M USD +5.26%
Lessee, Operating Lease, Liability, to be Paid, Year Four 112K USD
Additional Paid in Capital 18.1M USD +28.9%
Amortization of Intangible Assets 0 USD -100%
Share-based Payment Arrangement, Expense 326 USD -26.4%